Access cutting-edge advanced solid tumors treatment through this clinical trial at a research site in Dallas. Study-provided care at no cost to qualified participants.
Access advanced solid tumors specialists in Dallas at no cost
This study follows strict safety protocols and ethical guidelines
All study-related advanced solid tumors treatment provided free
Phase 1 (Dose Escalation) of this study will assess the safety, tolerability, dose-limiting toxicity (DLT), and will determine the maximum tolerated dose (MTD) and recommended Phase 2 dose (RP2D) of EU101 in participants with advanced solid tumors. Phase 2 (Dose Expansion) of the study will assess the antitumor effect of EU101 in two indications including colorectal cancer (CRC) and non-small cell lung cancer (NSCLC).
Sponsor: Eutilex
Check if you qualify for this advanced solid tumors clinical trial in Dallas, TX
If you're searching for advanced solid tumors treatment options in Dallas, TX, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Dallas research site is actively enrolling participants for this clinical trial. You'll receive care from experienced advanced solid tumors specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.